Inflammation but not endothelial dysfunction is associated with the severity of coronary artery disease in dyslipidemic subjects

Mediators of Inflammation

Volumn 2009, Issue , 2009, Pages

  Lahera, Vicente ^b   Rueda Clausen, Christian F ^a,b   Lpez Jaramillo, Patricio ^a,c   Luengas, Carlos ^a   Oubia, Maria Del Pilar ^b   Cachofeiro, Victoria ^b  

^a Instituto de Investigaciones   (Colombia)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^c UNIVERSIDAD DE SANTANDER   (Colombia)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CALCIUM CHANNEL BLOCKING AGENT; CHOLESTEROL; CLOPIDOGREL; CREATININE; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FUROSEMIDE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROCHLOROTHIAZIDE; INTERLEUKIN 1BETA; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NITRATE; NITRITE; NONSTEROID ANTIINFLAMMATORY AGENT; PADGEM PROTEIN; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; AGED; ANALYZER; ANTHROPOMETRIC PARAMETERS; ARTERY BLOOD FLOW; ARTERY DILATATION; ARTICLE; ATHEROSCLEROSIS; BLOOD SAMPLING; BODY MASS; BRACHIAL ARTERY; CAROTID ARTERY; CORONARY ARTERY DISEASE; CYTOKINE RELEASE; DYSLIPIDEMIA; ENZYME IMMUNOASSAY; FLOW MEDIATED DILATATION; HUMAN; INFLAMMATION; INTIMA; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; PRIORITY JOURNAL; THICKNESS; TUNICA MEDIA; ULTRASOUND; WAIST CIRCUMFERENCE; BLOOD; METABOLISM; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; VASCULAR ENDOTHELIUM;

ADULT; AGED; C-REACTIVE PROTEIN; CORONARY ARTERY DISEASE; DYSLIPIDEMIAS; ENDOTHELIUM, VASCULAR; HUMANS; INFLAMMATION; INTERLEUKIN-1BETA; INTERLEUKIN-6; MALE; MIDDLE AGED; NITRATES; NITRITES; P-SELECTIN; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR CELL ADHESION MOLECULE-1;

EID: 68249147814     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2009/469169     Document Type: Article

References (35)

1. de las Heras N., Cediel E., Oubia M. P., Comparison between the effects of mixed dyslipidaemia and hypercholesterolaemia on endothelial function, atherosclerotic lesions and fibrinolysis in rabbits Clinical Science 2003 104 4 357 365
2. Lpez-Jaramillo P., Casas J. P., Bautista L., Serrano N. C., Morillo C. A., An integrated proposal to explain the epidemic of cardiovascular disease in a developing country: from socioeconomic factors to free radicals Cardiology 2001 96 1 1 6
3. de Lombera Romero F., Fernndez Casares S., Gascuea Rubia R., Hypertension and dyslipidemia Revista Espanola de Cardiologia 1998 51 supplement 4 24 35
4. Sanchez-Recalde A., Kaski J. C., Diabetes mellitus, inflammation and coronary atherosclerosis: current and future perspectives Revista Espanola de Cardiologia 2001 54 6 751 763
5. Lpez-Farr A., Farr J., Snchez de Miguel L., Romero J., Gonzlez-Fernndez F., Casado S., Endothelial dysfunction: a global response Revista Espanola de Cardiologia 1998 51 supplement 6 18 22
6. Campuzano R., Moya J. L., Garca-Lled A., Endothelial dysfunction and intima-media thickness in relation to cardiovascular risk factors in patients without clinical manifestations of atherosclerosis Revista Espanola de Cardiologia 2003 56 6 546 554
7. Neunteufl T., Katzenschlager R., Hassan A., Systemic endothelial dysfunction is related to the extent and severity of coronary artery disease Atherosclerosis 1997 129 1 111 118
8. Mason R. P., Nitric oxide mechanisms in the pathogenesis of global risk Journal of Clinical Hypertension 2006 8 8, supplement 2 31 38
9. Libby P., Ridker P. M., Maseri A., Inflammation and atherosclerosis Circulation 2002 105 9 1135 1143
10. Hansson G. K., Robertson A.-K. L., Sderberg-Nauclr C., Inflammation and atherosclerosis Annual Review of Pathology 2006 1 297 329
11. Charo I. F., Taubman M. B., Chemokines in the pathogenesis of vascular disease Circulation Research 2004 95 9 858 866
12. de Groot E., van Leuven S. I., Duivenvoorden R., Measurement of carotid intima-media thickness to assess progression and regression of atherosclerosis Nature Clinical Practice Cardiovascular Medicine 2008 5 5 280 288
13. Sanchs Fors J., Bod V., Llcer., Relationship of C-reactive protein levels with angiographic findings and markers of necrosis in non-ST-segment elevation acute coronary syndrome Revista Espanola de Cardiologia 2004 57 5 382 387
14. Blake G. J., Ridker P. M., C-reactive protein and other inflammatory risk markers in acute coronary syndromes Journal of the American College of Cardiology 2003 41 4, supplement 1 37S 42S
15. Ridker P. M., Buring J. E., Rifai N., Cook N. R., Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the reynolds risk score Journal of the American Medical Association 2007 297 6 611 619
16. Sukhija R., Fahdi I., Garza L., Inflammatory markers, angiographic severity of coronary artery disease, and patient outcome The American Journal of Cardiology 2007 99 7 879 884
17. Lpez-Jaramillo P., Defining the research priorities to fight the burden of cardiovascular diseases in Latin America Journal of Hypertension 2008 26 9 1886 1889
18. Oubia M. P., de las Heras N., Cediel E., Synergistic effect of angiotensin-converting enzyme (ACE) and 3-hydroxy-3-methyl-glutaryl-CoA (HMG-CoA) reductase inhibition on inflammatory markers in atherosclerotic rabbits Clinical Science 2003 105 6 655 662
19. Maeso R., Aragoncillo P., Navarro-Cid J., Effect of atorvastatin on endothelium-dependent constrictor factors in dyslipidemic rabbits General Pharmacology 2000 34 4 263 272 (Pubitemid 32244093)
20. Aragoncillo P., Maeso R., Vzquez-Prez S., The protective role of atorvastatin on function, structure and ultrastructure in the aorta of dyslipidemic rabbits Virchows Archiv 2000 437 5 545 554
21. Anthropometry procedures manual,. National health and nutrition examination survey, 2002, http://www.Cdc.Gov/nchs
22. Ishibashi T., Yoshida J., Nishio M., Evaluation of NOx in the cardiovascular system: relationship to NO-related compounds in vivo Japanese Journal of Pharmacology 1999 81 4 317 323
23. Corretti M. C., Anderson T. J., Benjamin E. J., Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the international brachial artery reactivity task force Journal of the American College of Cardiology 2002 39 2 257 265
24. Silva S. Y., Villamizar C., Villamizar N., Colombian study to assess the use of noninvasive determination of the endothelium-mediated vasodilation (CANDEV) II. Does location of the occlusion device affects the accuracy of the diagnosis? Endothelium 2005 12 3 107 111
25. Accini J. L., Sotomayor A., Trujillo F., Barrera J. G., Bautista L., Lpez-Jaramillo P., Colombian study to assess the use of noninvasive determination of endothelium-mediated vasodilatation (CANDEV). Normal values and factors associated Endothelium 2001 8 2 157 166
26. Spence J. D., Ultrasound measurement of carotid plaque as a surrogate outcome for coronary artery disease The American Journal of Cardiology 2002 89 4, supplement 1 10B 16B
27. Meredith I. T., Plunkett J. C., Worthley S. G., Hope S. A., Cameron J. D., Systemic inflammatory markers in acute coronary syndrome: association with cardiovascular risk factors and effect of early lipid lowering Coronary Artery Disease 2005 16 7 415 422
28. Bautista L. E., Lpez-Jaramillo P., Vera L. M., Casas J. P., Otero A. P., Guaracao A. I., Is C-reactive protein an independent risk factor for essential hypertension? Journal of Hypertension 2001 19 5 857 861
29. Muhlestein J. B., May H. T., Jensen J. R., The reduction of inflammatory biomarkers by statin, fibrate, and combination therapy among diabetic patients with mixed dyslipidemia. The DIACOR (Diabetes and Combined Lipid Therapy Regimen) Study Journal of the American College of Cardiology 2006 48 2 396 401
30. van Boven A. J., Jukema J. W., Paoletti R., Endothelial dysfunction and dyslipidemia: possible effects of lipid lowering and lipid modifying therapy Pharmacological Research 1994 29 3 261 272
31. Anderson T. J., Prognostic significance of brachial flow-mediated vasodilation Circulation 2007 115 18 2373 2375
32. Yeboah J., Crouse J. R., Hsu F.-C., Burke G. L., Herrington D. M., Brachial flow-mediated dilation predicts incident cardiovascular events in older adults: the cardiovascular health study Circulation 2007 115 18 2390 2397
33. Shantsila E., Watson T., Lip G. Y. H., Statins and inflammation: reciprocal effectors to endothelial progenitors? Thrombosis Research 2008 123 1 1 4
34. Kostapanos M. S., Milionis H. J., Elisaf M. S., Review: an overview of the extra-lipid effects of rosuvastatin Journal of Cardiovascular Pharmacology and Therapeutics 2008 13 3 157 174
35. Castro P. F., Miranda R., Verdejo H. E., Pleiotropic effects of atorvastatin in heart failure: role in oxidative stress, inflammation, endothelial function, and exercise capacity Journal of Heart and Lung Transplantation 2008 27 4 435 441